◆ TICKERBASEVista interattiva →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › Tutte le azioni › 3088 · English version

MatsukiyoCocokara & Co. (3088)

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-30

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in franchise business development and product supply to franchisees, as well as management support services. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.

Dati chiave

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico2026-03-312025-03-312024-03-312023-03-312022-03-31
Entrate totaliJPY 1.12TJPY 1.06TJPY 1.02TJPY 951.2B—
Utile lordoJPY 393.8BJPY 372.2BJPY 354.1BJPY 329.3B—
Risultato Operativo (EBIT)JPY 84.9BJPY 82.1BJPY 75.7BJPY 62.3B—
Reddito nettoJPY 55.8BJPY 54.7BJPY 52.3BJPY 40.5B—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 3088. /companies/us/3088

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.